Integrated Bioinformatic and Experimental Analyses Identify CNTN6 as a Tumor-Promoting Factor and Prognostic Biomarker in Hepatocellular Carcinoma
Frontiers in Bioscience-Landmark · 23.10.2026 · 31 (10)
DOI: 10.31083/fbl55597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 23.10.2026. Verfasst von Ranzhiqiang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Sir Run Run Hospital of Nanjing Medical University, 211166 Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Commission of Health, Jiangsu Province Graduate Student Practice and Innovation Program.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) remains a highly lethal malignancy, and reliable biomarkers are needed for prognostic stratification and the development of therapeutic strategies. Contactin-6 (CNTN6), a member of the immunoglobulin superfamily of cell-adhesion molecules, has not been fully characterized in HCC.
Methods
Public datasets were used to evaluate CNTN6 expression, clinicopathological associations, immune-cell infiltration, prognostic value, and correlations with drug sensitivity in HCC. The biological functions of CNTN6 were assessed using HCC cell lines and xenograft models with CNTN6 knockdown and overexpression.
Results
CNTN6 was upregulated in HCC tissues and was associated with several clinicopathological features. Elevated CNTN6 expression was associated with poor survival outcomes and an M2-like macrophage infiltration signature. Functional enrichment analysis suggested that CNTN6-related proteins may participate in cell migration and oncogenic signaling pathways. In vitro, CNTN6 knockdown suppressed HCC cell proliferation, colony formation, migration, and invasion, whereas CNTN6 overexpression enhanced these malignant phenotypes. In vivo, CNTN6 knockdown reduced xenograft tumor growth and altered CD86/CD206 immunostaining patterns.
Conclusions
CNTN6 is upregulated in HCC and may function as a tumor-promoting factor associated with poor prognosis and macrophage-related immune remodeling. Further mechanistic and clinical validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Sir Run Run Hospital of Nanjing Medical University, 211166 Nanjing, Jiangsu, China.
- Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, 410005 Changsha, Hunan, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Commission of Health
- Jiangsu Province Graduate Student Practice and Innovation Program
Zitieren
APA
Yang, R., Yi, J., Zhang, J., Peng, Y., Gao, W., & Yu, C. (2026). Integrated Bioinformatic and Experimental Analyses Identify CNTN6 as a Tumor-Promoting Factor and Prognostic Biomarker in Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl55597
Vancouver
Yang R, Yi J, Zhang J, Peng Y, Gao W, Yu C. Integrated Bioinformatic and Experimental Analyses Identify CNTN6 as a Tumor-Promoting Factor and Prognostic Biomarker in Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl55597
BibTeX
@article{Yang2026,
author = {Yang, Ranzhiqiang and Yi, Jianing and Zhang, Jiyuan and Peng, Yuhuai and Gao, Wenjie and Yu, Chunzhao},
title = {Integrated Bioinformatic and Experimental Analyses Identify CNTN6 as a Tumor-Promoting Factor and Prognostic Biomarker in Hepatocellular Carcinoma},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {10},
doi = {10.31083/fbl55597}
}
EUVIMED